BioSpace News Archive

Limitless Venture Group, Inc. (“LVGI” or “the Company”) today announced it has acquired the majority interest in Jasper Benefit Solutions LLC, an MGU, through an equity and capitalization agreement.

Cellaria Inc (Wakefield, MA, USA) and the Spring Lab, Northeastern University, announce the successful receipt of a National Institutes of Health (NIH) R01 grant to extend and advance the application of innovative new photomedicine-based therapies for hard-to-treat cancers. The grant highlights the close working relationshi

New Orders and Production Growing; Employment Contracting; Supplier Deliveries Slowing at Faster Rate; Backlog Growing; Raw Materials Inventories Growing; Customers’ Inventories Too Low; Prices Increasing; Exports and Imports Growing

Dragonfly Therapeutics, Inc. (“Dragonfly”), today announced that Merck, known as MSD outside the United States and Canada , has licensed its first TriNKET™ immunotherapy candidate from Dragonf

OptaSensor now released the smallest commercially available digital camera, with high resolution, just 1x1mm in size and a volume of 1,7mm³ only.

Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer’s disease, today provided a corporate update to the market, as well as an outlook for the Company as it heads into 2021.

Enzolytics, Inc. Completes Merger with BioClonetics Immunotherapeutics, Inc.

Rafarma Pharmaceuticals, Inc.OTC:(RAFA) has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia (https://vaccineslab.com/).

LUCA Science (Tokyo, Japan), a biotechnology company pioneering a novel class of mitochondrial therapeutics, announced today that it will collaborate with the Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine to initiate a joint research on the development of mitochondrial therapy for cardiac ischemic–reperfusion injury.

Bora Pharmaceuticals Co., Ltd announced today that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK’s Mississauga, Ontario (Canada ) facility. Initially announced in March 2020 , the site represents Bora Pharmaceuticals’ first manufacturing facility in North A